TWA
QTTB icon

TCI Wealth Advisors’s Q32 Bio QTTB Stock Holding History

TCI Wealth Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-51
Closed -$3K – 2496
2021
Q4 		$3K Buy
51
+39
+325% +$3.79K ﹤0.01% 2049
2021
Q3 		$2K Hold
12
– – ﹤0.01% 2191
2021
Q2 		$2K Sell
12
-6
-33% -$749 ﹤0.01% 2120
2021
Q1 		$3K Buy
+18
New +$3.79K ﹤0.01% 1613

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

TCI Wealth Advisors's QTTB Position: Q1 2022 in Review

TCI Wealth Advisors sold out of Q32 Bio (QTTB) in Q1 2022, closing a stake of 51 shares — an estimated $3K sold.

TCI Wealth Advisors first reported a position in QTTB in Q1 2021 and held it in 4 quarters. The position peaked at $3K in Q4 2021. 106 funds tracked by Wall St. Rank hold QTTB as of Q1 2022.

  • TCI Wealth Advisors reported no remaining Q32 Bio position as of Q1 2022 after selling out during the quarter.
  • TCI Wealth Advisors sold 51 Q32 Bio shares in Q1 2022, an estimated $3K.
  • TCI Wealth Advisors first reported a position in Q32 Bio in Q1 2021 and held it in 4 quarters.
  • TCI Wealth Advisors's Q32 Bio position peaked at $3K in Q4 2021.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2022.

Based on TCI Wealth Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.